Domenichini Giulia, Le Bloa Mathieu, Carroz Patrice, Graf Denis, Herrera-Siklody Claudia, Teres Cheryl, Porretta Alessandra Pia, Pascale Patrizio, Pruvot Etienne
Cardiology Service, University Hospital of Lausanne, Lausanne, Switzerland.
Front Cardiovasc Med. 2022 Feb 23;9:783576. doi: 10.3389/fcvm.2022.783576. eCollection 2022.
Over the last decades, the implementation of new technology in cardiac pacemakers and defibrillators as well as the increasing life expectancy have been associated with a higher incidence of transvenous lead complications over time. Variable degrees of venous stenosis at the level of the subclavian vein, the innominate trunk and the superior vena cava are reported in up to 50% of implanted patients. Importantly, the number of implanted leads seems to be the main risk factor for such complications. Extraction of abandoned or dysfunctional leads is a potential solution to overcome venous stenosis in case of device upgrades requiring additional leads, but also, in addition to venous angioplasty and stenting, to reduce symptoms related to the venous stenosis itself, i.e., the superior vena cava syndrome. This review explores the role of transvenous lead extraction procedures as therapeutical option in case of central venous disorders related to transvenous cardiac leads. We also describe the different extraction techniques available and other clinical indications for lead extractions such as lead infections. Finally, we discuss the alternative therapeutic options for cardiac stimulation or defibrillation in case of chronic venous occlusions that preclude the implant of conventional transvenous cardiac devices.
在过去几十年中,心脏起搏器和除颤器新技术的应用以及预期寿命的延长,使得经静脉导线并发症的发生率随时间推移而升高。据报道,高达50%的植入患者在锁骨下静脉、无名静脉和上腔静脉水平出现不同程度的静脉狭窄。重要的是,植入导线的数量似乎是此类并发症的主要危险因素。在需要额外导线进行设备升级的情况下,拔除废弃或功能失调的导线是克服静脉狭窄的一种潜在解决方案,此外,除了静脉血管成形术和支架置入术外,还可减轻与静脉狭窄本身相关的症状,即上腔静脉综合征。本综述探讨了经静脉导线拔除术在与经静脉心脏导线相关的中心静脉疾病中的治疗作用。我们还描述了可用的不同拔除技术以及导线拔除的其他临床指征,如导线感染。最后,我们讨论了在慢性静脉闭塞导致无法植入传统经静脉心脏设备的情况下,心脏刺激或除颤的替代治疗选择。